The study of ISO induced heart failure rat model

Experimental and Molecular Pathology

Volumn 88, Issue 2, 2010, Pages 299-304

  Feng, Weiwei ^a   Li, Weimin ^a  

^a THE FIRST AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

ISO induced HF rat model; Metalloproteinase; Myocardial fibrosis; Pro inflammatory

Indexed keywords

GELATINASE A; GELATINASE B; INTERLEUKIN 1; INTERLEUKIN 17; INTERLEUKIN 6; ISOPRENALINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ECHOCARDIOGRAPHY; HEART EJECTION FRACTION; HEART FAILURE; HEART MUSCLE FIBROSIS; IMMUNOHISTOCHEMISTRY; INFLAMMATORY INFILTRATE; MALE; MORTALITY; MYOFIBROBLAST; NONHUMAN; PROTEIN EXPRESSION; RAT; SURVIVAL RATE;

ANIMALS; ECHOCARDIOGRAPHY; ENDOMYOCARDIAL FIBROSIS; HEART FAILURE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INJECTIONS, SUBCUTANEOUS; INTERLEUKIN-1; INTERLEUKIN-17; INTERLEUKIN-6; ISOPROTERENOL; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; RATS; RATS, WISTAR; SURVIVORS;

RATTUS; RATTUS NORVEGICUS;

EID: 77950628797     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2009.10.011     Document Type: Article

References (15)

1. Bos R., Mougenot N., Médiani O., Vanhoutte P.M., Lechat P. Potassium canrenoate, an aldosterone receptor antagonist, reduces isoprenaline-induced cardiac fibrosis in the rat. Pharmacol. Exp. Ther. 2004, 309(3):1160-1166.
2. Bos R., Mougenot N., Findji L., Médiani O., Vanhoutte P.M., Lechat P. Inhibition of catecholamine-induced cardiac fibrosis by an aldosterone antagonist. J. Cardiovasc. Pharmacol. 2005, 45(1):8-13.
3. Chagoya de Sánchez V., Hernández-Muñoz R., López-Barrera F., Yañez L., Vidrio S., Suárez J., Cota-Garza M.D., Aranda-Fraustro A., Cruz D. Sequential changes of energy metabolism and mitochondrial function in myocardial infarction induced by isoproterenol in rats: a long-term and integrative study. Can. J. Physiol. Pharmacol. 1997, 75(12):1300-1311.
4. Feng W., Li W., Liu W., Wang F., Li Y., Yan W. IL-17 induces myocardial fibrosis and enhances RANKL/OPG and MMP/TIMP signaling in isoproterenol-induced heart failure. Exp. Mol. Pathol. 2009, Jun 13. [Electronic publication ahead of print].
5. Gan R.T., Li W.M., Xiu C.H., Shen J.X., Wang X., Wu S., Kong Y.H. Chronic blocking of beta 3-adrenoceptor ameliorates cardiac function in rat model of heart failure. Chin. Med. J. (Engl). 2007, 120(24):2250-2255. Dec 20.
6. Grimm D., Elsner D., Schunkert H., Pfeifer M., Griese D., Bruckschlegel G., Muders F., Riegger G.A., Kromer E.P. Development of heart failure following isoproterenol administration in the rat: role of the renin-angiotensin system. Cardiovasc. Res. 1998, 37(1):91-100.
7. Hasenfuss G. Animal models of human cardiovascular disease. Heart failure and hypertrophy. Cardiovasc. Res. 1998, 39(1):60-76.
8. Li Weimin, Ying Tian, Yihui Kong, Runtao Gan, Guifang Sun, Jingxia Shen Experimental study of model of isoproterenol-induced heart failure in the rat. Journal of Harbin Medical University 2003, 37(5):386-388.
9. Li L., Zhang S., Zhang Y., Yu B., Xu Y., Guan Z. Paracrine action mediate the antifibrotic effect of transplanted mesenchymal stem cells in a rat model of global heart failure. Mol. Biol. Rep. 2009, 36(4):725-731.
10. Liu W., Feng W., Wang F., Li W., Gao C., Zhou B., Ma M. Osteoprotegerin/RANK/RANKL axis in cardiac remodeling due to immuno-inflammatory myocardial disease. Exp. Mol. Pathol. 2008, 84(3):213-217.
11. Mladenka P., Semeckỳ V., Bobrovová Z., Nachtigal P., Vávrová J., Holecková M., Palicka V., Mazurová Y., Hrdina R. The effects of lactoferrin in a rat model of catecholamine cardiotoxicity. Biometals 2009, 22(2):353-361.
12. Radauceanu A., Ducki C., Virion J.M., Rossiqnol P., Mallat Z., McMurray J., Van Veldhuisen D.J., Tavazzi L., Mann D.L., Capiaumont-Vin J., Li M., Hanriot D., Zannad F. Extracellular matrix turnover and inflammatory markers independently predict functional status and outcome in chronic heart failure. J. Card. Fail. 2008, 14(6):467-474.
13. Rona G. Catecholamine cardiotoxicity. J. Mol. Cell. Cardiol. 1985, 17(4):291-306.
14. Rona G. Catecholamine cardiotoxicity. J. Mol. Cell. Cardiol. 1985, 17:291-306.
15. Saygili E., Rana O.R., Meyer C., Gemein C., Andrzejewski M.G., Ludwig A., Weber C., Schotten U., Krüttgen A., Weis J., Schwinger R.H., Mischke K., Rassaf T., Kelm M., Schauerte P. The angiotensin-calcineurin-NFAT pathway mediates stretch-induced up-regulation of matrix metalloproteinases-2/-9 in atrial myocytes. Basic Res. Cardiol. 2009, 104(4):435-448.